Singleron Biotechnologies and Hamilton Bonaduz AG today announced the official launch of Tensor under their strategic partnership.

On average when positive, Signatera tests have a 98%-99% rate of accurately predicting the presence of cancer depending on the cancer, and the false-positive rate is less than 2% to 1% depending on ...